2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Vulvar Neoplasms
2
Melanoma
2
Liver Metastases
2
Ulcer
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pathologic Processes
1
Pancreatic Neoplasms
1
Neoplastic Processes
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gynecological Cancers
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Breast Cancer Female
1
Interventions
pembrolizumab
2
Pemetrexed
2
nilotinib
1
glutathione pegylated liposomal doxorubicin
1
ficlatuzumab
1
Zoledronic Acid
1
Trastuzumab
1
Radiosurgery
1
MRX-2843
1
Everolimus
1
Electrochemotherapy
1
Denosumab
1
Cisplatin
1
Carboplatin
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Processes
×
Electrochemotherapy
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled